Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
PATEO (02889) Signs Strategic Cooperation Framework Agreement with Shanghai Jiao Tong University to Drive Innovation Breakthroughs in the Field of Embodied Intelligence Based on Open Source HarmonyOS.
Zhida Technology (02650) has been included in the Hang Seng Composite Index and included in the list of stocks eligible for the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect.
SSY GROUP (02005): Obtain drug production registration approval for compound electrolyte sodium acetate glucose injection (250ml and 500ml) and metoclopramide hydrochloride injection (2ml:10mg).
PATEO (02889) Signs Strategic Cooperation Framework Agreement with Shanghai Jiao Tong University to Drive Innovation Breakthroughs in the Field of Embodied Intelligence Based on Open Source HarmonyOS.
Zhida Technology (02650) has been included in the Hang Seng Composite Index and included in the list of stocks eligible for the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect.
SSY GROUP (02005): Obtain drug production registration approval for compound electrolyte sodium acetate glucose injection (250ml and 500ml) and metoclopramide hydrochloride injection (2ml:10mg).
RECOMMEND
